Systemic lupus erythematosus (SLE): Cyto- and chemokines as possible serum markers for pulmonary involvement? Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012
Management of PAH associated with systemic lupus erythematosus (SLE) or mixed connective tissue disease (MCTD): immunosuppressive therapy (IT) alone or combined with PAH specific therapies? Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007
Examining pulmonary function measures in patients with systemic lupus erythematosus (SLE) Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases Year: 2020
Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus Source: Eur Respir Rev 2011; 20: 277-286 Year: 2011
Lung involvement in systemic lupus erythematosus (SLE) - our own experience Source: Eur Respir J 2002; 20: Suppl. 38, 60s Year: 2002
Immunosuppression in systemic lupus erythematosus associated pulmonary arterial hypertension (SLE-APAH): Improvement in exercise and functional capacity Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011
A functionally improved case of obstructive impairment caused by systemic lupus erythematosus Source: Breathe, 17 (2) 200288; 10.1183/20734735.0288-2020 Year: 2021
Management and prognosis of respiratory manifestations revealing systemic lupus erythematosus Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007
Pulmonary involvement in systemic lupus erythematosus, Sjögren syndrome and mixed connective tissue disease Source: Eur Respir Monogr 2019; 86: 106-123 Year: 2019
Lung abnormalities in patients with systemic lupus erythematosus Source: Eur Respir J 2001; 18: Suppl. 33, 225s Year: 2001
Endothelium dysfunction in systemic lupus erythematosus patients with pulmonary hypertension Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011
Pulmonary arterial hypertension and systemic lupus erythematosus Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009
Effectiveness of ²Korargin² in the therapy of pulmonary arterial hypertension in patients with systemic lupus erythematosus Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011
Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study Source: ERJ Open Res, 4 (1) 00135-2017; 10.1183/23120541.00135-2017 Year: 2018
Interstitial lung disease associated with systemic lupus erythematosus : a monocentric study of 23 cases. Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021
Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016
On diagnostics of pneumonitis in patients with lupus erythematosus (LE) Source: Eur Respir J 2005; 26: Suppl. 49, 31s Year: 2005
The profile of lung scintigraphy in systemic lupus erythematosus with chronic pulmonary embolism:a cross-section Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020
The nitroxidergic system state at systemic lupus erythematosus-associated pulmonary hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010
Cardio-pulmonary exercise testing in systemic lupus erythematosus patients Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005